Beautiful talk by @obenaufa.bsky.social at #THPT25 — first walking us through the key conclusions of her latest Nature paper, then offering a glimpse into the next chapter of her work unravelling the mysteries of drug tolerant persistent cells. Looking forward to see where this story goes next!
Three more days to apply for the *Swiss Bridge Award*! This time focusing on Tumor Heterogeneity. It truly is a wonderful grant opportunity with maximum flexibility for an innovative project. www.swissbridge.ch/call-for-app...
Really exciting lineup of speakers in a beautiful venue. I really look forward to it! #cancerimmunology
#Agenda
Via @obenaufa.bsky.social
@fusionconf.bsky.social
Amazing talk by @johannajoyce.bsky.social at #THPT25 — an impressive tour de force, beautifully contextualizing two decades of work. 😍
🎉 Congratulations to our Anna Obenauf, IMP Senior Group Leader, who has been elected as a Corresponding Member of the Austrian Academy of Sciences, for her outstanding contributions to cancer research:
https://www.imp.ac.at/news/article/anna-obenauf-elected-to-the-austrian-academy-of-sciences
Coming originally from cancer biology and only more recently working in tumor immunology, this award means even more to me. Thank you for the trust and for so warmly welcoming me into the community.
Thrilled and honored to be awarded the 2025 EJI Ita Askonas Prize by @efis-immunology.bsky.social ! 🎉
So grateful to the committee and especially to my incredible team and collaborators — this wouldn’t be possible without you!
www.efis.org/news/2025-ej...
